Daniel Chicoine - Net Worth and Insider Trading
Daniel Chicoine Net Worth
The estimated net worth of Daniel Chicoine is at least $11,550 dollars as of 2024-11-13. Daniel Chicoine is the Director of NeuPath Health Inc and owns about 51,472 shares of NeuPath Health Inc (TSXV:NPTH) stock worth over $8,750. Daniel Chicoine is also the Director, Senior Officer of Crescita Therapeutics Inc and owns about 5,000 shares of Crescita Therapeutics Inc (TSX:CTX) stock worth over $2,800. Details can be seen in Daniel Chicoine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Chicoine has not made any transactions after 2023-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Chicoine
Daniel Chicoine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Chicoine owns 2 companies in total, including NeuPath Health Inc (TSXV:NPTH) , and Crescita Therapeutics Inc (TSX:CTX) .
Click here to see the complete history of Daniel Chicoine’s form 4 insider trades.
Insider Ownership Summary of Daniel Chicoine
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSXV:NPTH | NeuPath Health Inc | 2023-05-02 | Director |
TSX:CTX | Crescita Therapeutics Inc | 2021-12-15 | Director & Senior Officer |
Daniel Chicoine Latest Holdings Summary
Daniel Chicoine currently owns a total of 2 stocks. Among these stocks, Daniel Chicoine owns 51,472 shares of NeuPath Health Inc (TSXV:NPTH) as of May 2, 2023, with a value of $8,750 and a weighting of 75.76%. Daniel Chicoine also owns 5,000 shares of Crescita Therapeutics Inc (TSX:CTX) as of December 15, 2021, with a value of $2,800 and a weighting of 24.24%.
Latest Holdings of Daniel Chicoine
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSXV:NPTH | NeuPath Health Inc | 2023-05-02 | 51,472 | 0.17 | 8,750 |
TSX:CTX | Crescita Therapeutics Inc | 2021-12-15 | 5,000 | 0.56 | 2,800 |
Holding Weightings of Daniel Chicoine
Daniel Chicoine Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Chicoine has made a total of 2 transactions in NeuPath Health Inc (TSXV:NPTH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NeuPath Health Inc is the acquisition of 22,222 shares on May 2, 2023, which cost Daniel Chicoine around $2,000.
According to the SEC Form 4 filings, Daniel Chicoine has made a total of 3 transactions in Crescita Therapeutics Inc (TSX:CTX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Crescita Therapeutics Inc is the acquisition of 5,000 shares on December 15, 2021, which cost Daniel Chicoine around $3,400.
Insider Trading History of Daniel Chicoine
- 1
Daniel Chicoine Trading Performance
GuruFocus tracks the stock performance after each of Daniel Chicoine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Chicoine is -7.56%. GuruFocus also compares Daniel Chicoine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Chicoine within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Chicoine's insider trading performs compared to the benchmark.
Performance of Daniel Chicoine
Daniel Chicoine Ownership Network
Ownership Network List of Daniel Chicoine
Ownership Network Relation of Daniel Chicoine
Daniel Chicoine Owned Company Details
What does NeuPath Health Inc do?
Who are the key executives at NeuPath Health Inc?
Daniel Chicoine is the Director of NeuPath Health Inc. Other key executives at NeuPath Health Inc include Senior Officer Grant Connelly , and Senior Officer Stephen Lemieux .
NeuPath Health Inc (TSXV:NPTH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeuPath Health Inc (TSXV:NPTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeuPath Health Inc (TSXV:NPTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeuPath Health Inc (TSXV:NPTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuPath Health Inc Insider Transactions
Daniel Chicoine Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Chicoine. Currently GuruFocus does not have mailing address information for Daniel Chicoine.